Celecoxib extends C. elegans lifespan via inhibition of insulin-like signaling but not cyclooxygenase-2 activity
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
One goal of aging research is to develop interventions that combat age-related illnesses and slow aging. Although numerous mutations have been shown to achieve this in various model organisms, only a handful of chemicals have been identified to slow aging. Here, we report that celecoxib, a nonsteroidal anti-inflammatory drug widely used to treat pain and inflammation, extends Caenorhabditis elegans lifespan and delays the age-associated physiological changes, such as motor activity decline. Celecoxib also delays the progression of age-related proteotoxicity as well as tumor growth in C. elegans. Celecoxib was originally developed as a potent cyclooxygenase-2 (COX-2) inhibitor. However, the result from a structural-activity analysis demonstrated that the antiaging effect of celecoxib might be independent of its COX-2 inhibitory activity, as analogs of celecoxib that lack COX-2 inhibitory activity produce a similar effect on lifespan. Furthermore, we found that celecoxib acts directly on 3'-phosphoinositide-dependent kinase-1, a component of the insulin/IGF-1 signaling cascade to increase lifespan.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sirtuin activators mimic caloric restriction and delay ageing in metazoans
Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., & Sinclair, D. (2004) · Nature · doi:10.1038/nature02789 · Cited by 1,868 · cited 1×
“These include a sirtuin activator resveratrol (Wood et al., 2004; Bass et al., 2007), an antihyperglycemic drug metformin (Onken & Driscoll, 2010), a variety of antioxidants (e.g. vitamin E) (Harrington & Harley, 1988; Adachi & Ishii, 2000; Melov et al., 2000), and several serotonin receptor…”
BackgroundRegulation of aging and age-related disease by DAF-16 and heat-shock factor
Hsu, A.-L., Murphy, C. T., & Kenyon, C. (2003) · Science · doi:10.1126/science.1083701 · Cited by 1,513 · cited 2×
“…Publishing Ltd/Anatomical Society of Great Britain and Ireland 511 ation associated with aberrant protein aggregations (e.g. Alzheimer’s and Huntington’s disease) as well as tumor growth in C. elegans disease models (Morley et al., 2002; Hsu et al., 2003; Cohen et al., 2006; Pinkston et al., 2006).”
BackgroundSelf-citationA subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388 · cited 1×
“Recent studies have reported that a subset of NSAIDs can lower the production of amyloidigenic Ab42 or Ab40 peptides, potentially independent of its COX inhibitory activity (Weggen et al., 2001; Gasparini et al., 2004).”
BackgroundThe plasticity of aging: insights from long-lived mutants
Kenyon, C. (2005) · Cell · doi:10.1016/j.cell.2005.02.002 · Cited by 1,338 · cited 1×
“For example, mutations inhibiting the insulin ⁄ IGF-1-like signaling (IIS) have been shown to extend lifespan and delay various age-related physiological changes (Guarente & Kenyon, 2000; Garigan et al., 2002; Herndon et al., 2002; Kenyon, 2005).”
BackgroundStochastic and genetic factors influence tissue-specific decline in ageing C. elegans
Herndon, L. A., Schmeissner, P. J., Dudaronek, J. M., Brown, P. A., Listner, K. M., Sakano, Y., Paupard, M. C., Hall, D. H., & Driscoll, M. (2002) · Nature · doi:10.1038/nature01135 · Cited by 1,214 · cited 1×
“For example, mutations inhibiting the insulin ⁄ IGF-1-like signaling (IIS) have been shown to extend lifespan and delay various age-related physiological changes (Guarente & Kenyon, 2000; Garigan et al., 2002; Herndon et al., 2002; Kenyon, 2005).”
BackgroundNonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
in 't Veld, B. A., Ruitenberg, A., Hofman, A., Launer, L. J., van Duijn, C. M., Stijnen, T., Breteler, M. M. B., & Stricker, B. H. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010178 · Cited by 1,196
Rates of Behavior and Aging Specified by Mitochondrial Function During Development
Dillin, A., Hsu, A.-L., Arantes-Oliveira, N., Lehrer-Graiwer, J., Hsin, H., Fraser, A. G., Kamath, R. S., Ahringer, J., & Kenyon, C. (2002) · Science · doi:10.1126/science.1077780 · Cited by 1,121 · cited 2×
“For instance, the IIS functions during early adulthood to regulate longevity (Dillin et al., 2002a).”
BackgroundSelf-citationLithgow, G. J., White, T. M., Melov, S., & Johnson, T. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7540 · Cited by 862
Opposing activities protect against age-onset proteotoxicity
Cohen, E., Bieschke, J., Perciavalle, R. M., Kelly, J. W., & Dillin, A. (2006) · Science · doi:10.1126/science.1124646 · Cited by 843
Onken, B., & Driscoll, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008758 · Cited by 671 · cited 1×
“These include a sirtuin activator resveratrol (Wood et al., 2004; Bass et al., 2007), an antihyperglycemic drug metformin (Onken & Driscoll, 2010), a variety of antioxidants (e.g. vitamin E) (Harrington & Harley, 1988; Adachi & Ishii, 2000; Melov et al., 2000), and several serotonin receptor…”
Background
Cited by
Insulin/insulin-like growth factor signaling in C. elegans
Murphy, C. T. (2013) · WormBook · doi:10.1895/wormbook.1.164.1 · Cited by 532
The quest to slow ageing through drug discovery
Partridge, L., Fuentealba, M., & Kennedy, B. K. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0067-7 · Cited by 468
Therapeutic strategies targeting FOXO transcription factors
Calissi, G., Lam, E. W.-F., & Link, W. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0088-2 · Cited by 330
Influence of non-steroidal anti-inflammatory drugs on Drosophila melanogaster longevity
Danilov, A., Shaposhnikov, M., Shevchenko, O., Zemskaya, N., Zhavoronkov, A., & Moskalev, A. (2015) · Oncotarget · doi:10.18632/oncotarget.5118 · Cited by 64
Transgenic expression of cyclooxygenase-2 (COX2) causes premature aging phenotypes in mice
Kim, J., Vaish, V., Feng, M., Field, K., Chatzistamou, I., & Shim, M. (2016) · Aging · doi:10.18632/aging.101060 · Cited by 41
Metadata
- Authors
- Ching, T.-T., Chiang, W.-C., Chen, C.-S., & Hsu, A.-L.
- Venue
- Aging Cell
- Publisher
- Wiley
- Published
- 2011-04-07
- Volume
- 10
- Issue
- 3
- Pages
- 506-519
- ISSN
- 1474-9718 (ISSN-L)
- OpenAlex
- W1895023662
- Cited by
- 49
- References
- 12
- FWCI
- 0.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Celecoxib extends C. elegans lifespan via inhibition of insulin-like signaling but not cyclooxygenase-2 activity. https://app.cochat.ai/papers/10.1111/j.1474-9726.2011.00688.x
- The paper
- Ching, T.-T., Chiang, W.-C., Chen, C.-S., & Hsu, A.-L. (2011). Celecoxib extends C. elegans lifespan via inhibition of insulin-like signaling but not cyclooxygenase-2 activity. Aging Cell. https://doi.org/10.1111/j.1474-9726.2011.00688.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.